You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

clonal evolution

Showing 26 - 50 of 2,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acquired and Inherited Bone Marrow Failure Syndromes

Recruiting
  • Severe Aplastic Anemia
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 12, 2022

    Metabolic and Immune Dysfunction in In-transit Melanoma

    Recruiting
    • Melanoma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Feb 11, 2022

    MDS Patients Using Sequential Peripheral Blood Samples

    Recruiting
    • Myelodysplastic Syndromes
      • Badalona, Barcelona, Spain
        Josep Carreras Leukaemia Research Institute
      Mar 8, 2022

      Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

      Recruiting
      • Blastoid Variant Mantle Cell Lymphoma
      • +8 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

      Recruiting
      • Endometrial Cancer
      • Ovarian Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 27, 2022

      Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

      Available
      • Clear Cell Kidney Cancer
      • +2 more
      • Axitinib 5 MG
      • (no location specified)
      Jul 3, 2023

      Fanconi Anemia Trial in Madrid (Eltrombopag)

      Completed
      • Fanconi Anemia
      • Madrid, Spain
        Hospital Infantil Universitario Niño Jesús (HIUNJ)
      Sep 20, 2023

      Colorectal Cancer Trial in Milano, Candiolo, Padova (Panitumumab 20 MG/ML Intravenous Solution [VECTIBIX], Molecular Screening)

      Active, not recruiting
      • Colorectal Cancer
      • Panitumumab 20 MG/ML Intravenous Solution [VECTIBIX]
      • Molecular Screening
      • Milano, Via Giacomo Venezian, 1, Italy
      • +3 more
      Aug 26, 2021

      Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)

      Completed
      Has Results
      • Aplastic Anemia
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jul 2, 2021

      Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer

      Completed
      • Metastatic Breast Cancer
      • +2 more
      • ctDNA testing
      • (no location specified)
      Jun 16, 2022

      NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

      Recruiting
      • Non-small Cell Lung Cancer
      • London, United Kingdom
        Univeristy College London Hospital
      Feb 22, 2022

      Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation

      Recruiting
      • Lymphoma, Large B-Cell, Diffuse
        • Copenhagen, Denmark
          Department of Hematology, Rigshospitalet
        Jan 12, 2022

        Severe Aplastic Anemia Who Relapsed After Immunosuppressive

        Active, not recruiting
        • Severe Aplastic Anemia
          • Bethesda, Maryland
            National Heart, Lung and Blood Institute (NHLBI)
          Apr 7, 2022

          Rapid Autopsy and Procurement of Cancer Tissue

          Recruiting
          • Thymus Tumors
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 20, 2022

            Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine, Navitoclax, Venetoclax)

            Recruiting
            • Recurrent Acute Myeloid Leukemia
            • Refractory Acute Myeloid Leukemia
            • Duarte, California
              City of Hope Medical Center
            Aug 15, 2022

            Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

            Terminated
            • Refractory Aplastic Anemia
            • Tianjin, Tianjin, China
              Regenerative Medicine Center
            Aug 25, 2022

            Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

            Recruiting
            • Clonal Cytopenia of Undetermined Significance
            • Biospecimen Collection
            • +6 more
            • Columbus, Ohio
              Ohio State University Comprehensive Cancer Center
            Dec 12, 2022

            MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

            Active, not recruiting
            • Myelodysplastic Syndromes
            • Myeloproliferative Neoplasm
            • Azacitidine Subcutaneous Injection or Intravenous Infusion
            • +2 more
            • Miami, Florida
            • +4 more
            Jun 20, 2022

            Smoldering Multiple Myeloma Trial in Belgium, France, Monaco (Myelogram)

            Recruiting
            • Smoldering Multiple Myeloma
            • Myelogram
            • Bruxelles, Belgium
            • +89 more
            Aug 9, 2022

            Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

            Recruiting
            • Mantle Cell Lymphoma
            • Houston, Texas
              M D Anderson Cancer Center
            Nov 1, 2022

            Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)

            Recruiting
            • Severe Aplastic Anemia
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 27, 2023

            AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

            Not yet recruiting
            • AML, Adult
            • Amersfoort, Netherlands
            • +17 more
            Aug 23, 2023

            Severe Aplastic Anemia Trial in Paris (ATGAM plus CsA with or without Eltrombopag)

            Enrolling by invitation
            • Severe Aplastic Anemia
            • ATGAM plus CsA with or without Eltrombopag
            • Paris, France
              Hospital St. Louis
            Sep 21, 2021

            Aplastic Anemia Trial in China (Eltrombopag 25 mg)

            Active, not recruiting
            • Aplastic Anemia
            • Eltrombopag 25 mg
            • Nanjing, Jiangsu, China
            • +4 more
            Oct 7, 2021

            Acquired Aplastic Anemia Trial in Moscow (Eltrombopag, IST (ATG + CsA))

            Recruiting
            • Acquired Aplastic Anemia
            • Moscow, Russian Federation
              Dmitry Rogachev National Research Center of Pediatric Hematology
            Mar 12, 2021